Johnson & Johnson on Monday released its 2016 transparency report, which showed that the list prices of its pharmaceutical products in the US rose by an average of 8.5 percent, compared with the year before.
The drug was discovered and developed with scientists from US pharmaceutical companies AbbVie and Genentech, as part of an international collaboration with the Walter and Eliza Hall Institute